CRIP1 and osteosarcoma: They analyzed 223 pre-therapeutic and well-characterized osteosarcoma samples for the immunohistochemical expression of CRIP1 and correlated their findings with clinic-pathological parameters including follow-up, systemic spread and response to chemotherapy.